As of 2025-11-17, the Intrinsic Value of Spire Healthcare Group PLC (SPI.L) is 296.59 GBP. This SPI.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 225.00 GBP, the upside of Spire Healthcare Group PLC is 31.80%.
The range of the Intrinsic Value is 99.03 - 913.19 GBP
Based on its market price of 225.00 GBP and our intrinsic valuation, Spire Healthcare Group PLC (SPI.L) is undervalued by 31.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 99.03 - 913.19 | 296.59 | 31.8% |
| DCF (Growth 10y) | 200.77 - 1,157.32 | 434.97 | 93.3% |
| DCF (EBITDA 5y) | 103.85 - 242.66 | 164.68 | -26.8% |
| DCF (EBITDA 10y) | 204.41 - 436.67 | 304.03 | 35.1% |
| Fair Value | 22.94 - 22.94 | 22.94 | -89.81% |
| P/E | 63.22 - 145.01 | 101.90 | -54.7% |
| EV/EBITDA | 72.86 - 332.98 | 203.15 | -9.7% |
| EPV | 930.27 - 1,614.40 | 1,272.33 | 465.5% |
| DDM - Stable | 37.42 - 115.45 | 76.43 | -66.0% |
| DDM - Multi | 97.10 - 223.52 | 134.36 | -40.3% |
| Market Cap (mil) | 907.35 |
| Beta | 0.64 |
| Outstanding shares (mil) | 4.03 |
| Enterprise Value (mil) | 2,179.55 |
| Market risk premium | 5.98% |
| Cost of Equity | 9.08% |
| Cost of Debt | 9.96% |
| WACC | 8.49% |